More from the blog

  • All
  • About us
  • Campaigning
  • Dementia info
  • Fundraising
  • Living with dementia
  • Our scientists
  • Our supporters
  • Research

I run with a smile on my face because I find it easier

Clinton Page from Schroders Personal Wealth talks to us about what motivates him to run two marathons this year.

Love your brain with all your heart

Our 2021 Dementia Attitudes Monitor shows that although knowledge of the diseases that cause the condition is improving, understanding of how we can influence dementia risk, and particularly the link between heart and brain health, is lagging behind.

Introducing our new Director of EDoN

Mike Oldham has joined Alzheimer’s Research UK as our new Director of EDoN. We caught up with Mike to find out more about his background and the work he will be doing at Alzheimer’s Research UK.   What has been your career path to date? I’m an aeronautical engineer by training, spending the first part…

Government’s missed opportunity on research funding leaves dementia community disappointed

Dementia is one of the biggest health challenges of our lifetimes. This week the UK government had the chance to rise to that challenge and give hope to the nearly 1 million people living with dementia across the country. But in its Comprehensive Spending Review this week – where the government set out its spending…

How an Alzheimer’s Research UK cheer squad saved my marathon

I’m approaching mile 18 of the London Marathon and struggling. But then I spot a sea of orange ahead of me, and it all changes…

Join the giving revolution this Christmas – Alzheimer’s Research UK is proud to be part of innovative product line-up from Advent of Change

Alzheimer’s Research UK is pleased to be part of a unique product line-up for Christmas 2021, alongside 47 other charities. The feel-good festive range has been revealed in partnership with John Lewis by the non-profit social enterprise, Advent of Change, which pioneered the UK’s first advent calendar with a charity behind each door. This year,…

Five things we learned at the Alzheimer’s Research UK Clinical Conference 2021

It was fantastic to see so many clinicians engaging with each other and discussing a range of key topics across the clinical landscape during the Alzheimer’s Research UK Clinical Conference 2021. We made the decision to hold the event virtually because of the COVID-19 pandemic. But despite not being together in person, with more than…

What is involved in dementia research?

When dementia research hits the headlines, it tends to be about results from late-stage clinical trials where a new treatment or diagnostic tool is close to a breakthrough. While this type of research is particularly exciting, many other stages of research have taken place behind the scenes to get that study to the last crucial phase.

How you’re fuelling post-COVID hope in dementia research

2020/21 was one of the most challenging financial years of our history, but we’re so proud of what our incredible supporters enabled us to achieve.

6 ways leaving a gift in your will is helping drive progress in dementia research

Gifts in Wills protect our children, grandchildren and future generations from the fear, harm and heartbreak of dementia – here’s how these vital gifts have driven progress in research.

Eight phases of FTD

John Hirst’s wife, Pat, died in July from frontotemporal dementia. She was only 66.
To coincide with World FTD Awareness Week, John has written an account of his wife’s battle with FTD.

Why I’m Going for Gold at the London Marathon

Helen Beck explains why she joined the Going for Gold team running the Virgin Money London Marathon in honour of Olympic hockey gold medallist Imran Sherwani.

Why I’m running two marathons for dementia research this year – part two

Clinton Page from Schroders Personal Wealth talks to us about what motivates him to run two marathons this year.

How COVID-19 has changed our attitudes to dementia

Our collective experience of the COVID-19 pandemic has not only shaped the nations health but also our attitudes towards it, including dementia. This World Alzheimer’s Day, we’ve launched Wave 2 of our Dementia Attitudes Monitor. Find out how the UK’s perceptions of dementia are changing and where we still need to work harder.

Answering your questions about aducanumab

In June 2021, the United States Food and Drug Administration (FDA) made a landmark decision to approve the Alzheimer’s drug aducanumab (known commercially as Aduhelm). Although we are still waiting to learn whether aducanumab will be granted similar approval for use in the UK, this is the first time a drug has been approved for dementia…

How can we help millions understand dementia in 5 minutes?

We live in an information age. Knowledge on almost any topic is just a quick search away, and news updates are delivered as stories are still unfolding. But it can sometimes be difficult to know how to make sense of all the information that’s available to us.

Global dementia cases are set to triple, but what does this mean, what are we doing and how can you help?

With global dementia cases are set to triple by 2050 to no fewer than 152 million, we share what you can do to help.

Celebrating our dementia health information

Alzheimer’s Research UK strive to tackle the misconceptions that surround dementia. One way we achieve this is through the production of our free dementia health information.

Could an internet-based intervention help reduce dementia risk in the over 75s?

Linda Barnes talks to us about an exciting study exploring whether an internet-based intervention could encourage healthy lifestyle changes in older adults who are at a higher risk of developing dementia.

A story behind each signature: campaigner Olive Munro delivers petition to the Prime Minister

  Over 51,000 people signed our petition which was delivered to the Prime Minister today, by Alzheimer’s Research UK Campaigner Olive Munro. The petition calls on the government to outline how they will deliver their manifesto commitment to double funding for dementia research, over a year and a half after they made this promise. Our…

Why you should watch The Father

“Having just watched the Oscar award-winning film, The Father, I feel like I can understand what my own father must be experiencing.”

Why I’m running two marathons for dementia research this year

Clinton Page from Schroders Personal Wealth talks to us about what motivates him to run two marathons this year.

Our letter to Matt Hancock on aducanumab

Today the FDA in the US made a landmark decision to approve the Alzheimer’s drug aducanumab. The drug has been approved under the FDA’s Accelerated Approval pathway, which includes a requirement for Biogen, the pharmaceutical company that makes the drug, to conduct a further stage four clinical trial to collect evidence on its benefits to…

When could aducanumab reach the UK?

Today is a historic day for dementia research with the US Food and Drug Administration (FDA) announcing the first (conditional) licence of a new drug for Alzheimer’s disease in a generation.

parkrun could be one of your brain healthy habits

Chrissie Wellington OBE, parkrun’s Global Lead for Health and Wellbeing, talks to us about how the reopening of parkruns can help you achieve your Think Brain Health goals.